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ABSTRACT  23 
Over a quarter of the world’s population is at risk of infection with the soil-transmitted helminths; 24 
Ascaris lumbricoides, hookworm (Ancylostoma duodenale and Necator americanus), Trichuris 25 
trichiura, and Strongyloides stercoralis. Infected children and adults present with a range of medical 26 
and surgical conditions, and clinicians should consider the possibility of infection in individuals living 27 
in, or returning from, endemic regions. Although safe and effective drugs are donated free to 28 
endemic countries, only half of at risk children received treatment in 2016. This seminar describes 29 
the epidemiology, life cycles, pathophysiology, clinical diagnosis and management, and the public 30 
health control of soil-transmitted helminths. Recent reviews questioned the impact of population-31 
level deworming; however, it remains beyond doubt that treatment effectively reduces severe 32 
consequences of soil-transmitted helminthiasis. We highlight the need for refined diagnostic tools 33 
and more effective control options to scale up public-health interventions and to improve clinical 34 
detection and management of these infections.  35 
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INTRODUCTION  41 
Helminthic parasites are among the most common infections in humans.1 Due to the role of 42 
contaminated soil in their transmission cycle, infections with Ascaris lumbricoides, Trichuris trichiura, 43 
and hookworm (Ancylostoma duodenale and Necator americanus) are, in public health terms, known 44 
as soil-transmitted helminthiasis (STH). These parasites affect more than a quarter of the world’s 45 
population, and contribute to a substantial burden of human disease and disability.2 In this seminar 46 
we also address an additional soil-transmitted helminth - Strongyloides stercoralis - which is an 47 
important, but often neglected, cause of severe morbidity.3, 4 STH primarily affects individuals in 48 
communities with limited access to, and use of, water, sanitation, and hygiene (WASH) facilities5 and 49 
is the most widespread among the so-called neglected tropical diseases (NTDs).1  50 
The World Health Organization (WHO) and other partners currently support national governments in 51 
STH-endemic countries to implement large-scale, periodic anthelmintic treatment (with 52 
mebendazole or albendazole) of pre-school-age children, school-age children, and women of 53 
reproductive age (except in the first trimester of pregnancy).6 The primary, and currently most 54 
realistic, aim of such mass drug administration (MDA) is to control morbidity due to STH by reducing 55 
infection intensity and ultimately prevalence.7 Mass treatment complements clinical case 56 
management by preventing or curtailing chronic, high worm burden infections and associated 57 
disease.  58 
This seminar provides an overview of the state-of-the-art clinical diagnosis, management, and 59 
follow-up of STH, including a ‘Fast Facts’ clinical summary which can be used on a mobile device, to 60 
facilitate case identification and management (Panel 1). Importantly, we aim to bridge the evidence-61 
base for clinical case management with that of public health control to inform and leverage both 62 
approaches to morbidity control in endemic and non-endemic countries (Panel 2). Further, we 63 
discuss recent reviews that have questioned the health impact of population-level deworming in its 64 
current form, and we present the main arguments of the on-going debate that has followed. Panel 3 65 
shows the search strategies we used for this seminar review. 66 
 67 
EPIDEMIOLOGY  68 
Infections with soil-transmitted helminths are most common in people living in areas with limited 69 
access to adequate sanitation, and in emigrants and visitors returning from such areas. Although 70 
most endemic regions are found in low- and middle-income countries, STH also occurs in high-71 
income countries among vulnerable populations who are not reached by public-health measures.8-10 72 
The current geographical distribution of STH is shown in Figure 1A-D. In 2010, the WHO estimated 73 
that 875 million children were in need of regular treatment for STH, excluding S. stercoralis which is 74 
thought to infect up to 100 million people globally.1, 11 Data from the past decade suggest that 75 
disability-adjusted life years (DALYs) associated with STH have declined; however, this reduction has 76 
to a large extent been seen in upper-middle income countries, with the disease burden becoming 77 
even more concentrated in low- and lower-middle income countries.12 The DALY estimates have 78 
been disputed, with some scientists arguing that the numbers grossly under evaluate the true 79 
burden of disease, e.g. by inadequate attribution of iron-deficiency anaemia caused by hookworm 80 
infections.13  81 
Ascaris lumbricoides (roundworm) infects an estimated 804 million people worldwide, most 82 
commonly pre-school-age children, school-age children and adolescents in endemic countries.14-16 83 
Over the past 25 years, DALYs associated with Ascaris have dropped to around 1 million, now a 84 
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quarter of the Ascaris disease burden in 1990.17 Mortality accounts for approximately one-sixth of 85 
the current disease burden, whereas most of the severe morbidity averted is thought to be due to a 86 
reduction in severe wasting.2 Although the vast majority of infections occur in endemic countries, 87 
occasionally, zoonotic transmission of Ascaris suum occurs in individuals who have been in contact 88 
with domestic pigs, even in countries non-endemic for STH.18  89 
Trichuris trichiura (whipworm) infects an estimated 477 million individuals, and prevalence and 90 
intensity of infection are typically highest in children.16, 19, 20 However, data are scarce and suspicion 91 
of infection should not be limited by current endemicity maps.17 Over the past 10 years, the DALYs 92 
due to Trichuris have declined to just above 500,000;17 The majority of these averted DALYs have 93 
been due to lower trichuriasis infestations and fewer cases of mild abdominopelvic problems with a 94 
small reduction of more extreme cases, such as severe wasting. In addition, zoonotic transmission to 95 
humans can occur with Trichuris suis, as for A. suum.18  96 
Ancylostoma duodenale and Necator americanus (hookworm) infect an estimated 472 million 97 
people.16 In contrast to A. lumbricoides and T. trichiura, the prevalence and intensity of hookworm 98 
infection is highest in adults, although children are also commonly infected.21 Necator americanus is 99 
the most widely distributed hookworm species, found across sub-Saharan Africa, the Americas and 100 
Asia, whereas A. duodenale is found more focally. Both species may also co-exist in the same area 101 
and within the same individuals. The disease burden caused by hookworm is to a large extent due to 102 
anaemia, and recent estimates suggest that the burden of disease could be as high as 4,000,000 103 
DALYs, with considerable productivity losses of up to 139 billion US dollars annually worldwide.17, 22  104 
Strongyloides stercoralis (threadworm) infects up to 100 million people globally;1, 11 however, as 105 
with T. trichiura, the data are scarce and suspicion of infection should not be limited by endemicity 106 
maps.4, 11 Although uncommon, dogs, cats and other mammals may serve as reservoir hosts for 107 
human S. stercoralis infection, even where adequate sanitation exists. Additional risk factors for S. 108 
stercoralis infection include immunosuppression, certain malignancies, human T-cell lymphotropic 109 
virus (HTLV)-1 infection, and alcoholism.4, 11 In Central Africa S. fuelleborni, a non-human primate 110 
Strongyloides species, can also infect humans.  111 
 112 
LIFE CYCLES  113 
Ascaris lumbricoides infects humans through faecal-oral transmission (Figure 2A).23 After 114 
embryonated eggs are swallowed, first-stage (L1) larvae hatch from eggs, moult into second-stage 115 
(L2) larvae, penetrate the host intestinal mucosa, and migrate to the vascular system, through the 116 
right side of the heart to the pulmonary circulation. Too large to pass through the pulmonary 117 
capillaries, the third-stage (L3) larvae migrate across the alveolar wall and traverse along the 118 
tracheobronchial tree to the larynx, where they are swallowed and, in the small intestine, moult into 119 
fourth-stage (L4) larvae that develop into adult worms. With sexual reproduction, adult female A. 120 
lumbricoides worms can release thousands of eggs daily that pass into the environment through the 121 
stool. Egg production occurs two to three months following ingestion of infective eggs, and adult 122 
worms may live for a few years. Eggs can remain viable for several years in warm, moist soil.24  123 
Trichuris trichiura is transmitted through a faecal-oral cycle in which infective embryonated eggs 124 
typically are ingested via contaminated food or hands, and hatch into larvae that moult in the small 125 
intestine. Unlike A. lumbricoides, Trichuris does not include a migratory phase outside the intestine 126 
(Figure 2B).25 The larvae attach to the intestinal villi and develop into adult worms, which reside in 127 
the caecum and the ascending colon. Female worms lay thousands of eggs per day, and can survive 128 
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for several years. The eggs pass in the stool and embryonate in the soil, where they can survive in 129 
warm, moist conditions for months.24, 26  130 
Ancylostoma duodenale and N. americanus larvae are free-living in the soil, and infect humans by 131 
attaching to and penetrating the skin, typically through bare feet. The larvae are transported by 132 
lymph and blood to the right side of the heart and the pulmonary circulation (Figure 2C).23 In the 133 
pulmonary capillaries, the larvae penetrate the alveolar wall, pass to the larynx and are swallowed. 134 
The larvae moult and develop into mature worms in the small intestine over one to two months, and 135 
can live for several months (A. duodenale) or years (N. americanus). A female worm releases 136 
thousands of eggs a day that pass in the stool, and after five to ten days, hatch in warm, moist, sandy 137 
soil or in the faeces to produce rhabditiform, L1 larvae. Larvae feed on organic matter, and become 138 
infective after rapid moulting to L2 and L3 larvae that can survive for several weeks.24  139 
In addition to percutaneous infection, A. duodenale can also infect humans through ingestion of 140 
larvae, resulting in Wakana syndrome, especially in heavy infections. Hookworms may also remain 141 
dormant in connective tissue or muscle. Ancylostoma species that typically infect mammals, such as 142 
dogs and cats, may also infect humans, causing cutaneous larva migrans, a self-limiting skin 143 
infection. Recent data suggest that human infection with zoonotic species can cause pathology 144 
similar to A. duodenale and N. americanus, and may be more common than previously thought.27  145 
Strongyloides stercoralis follows a complex life cycle that may take multiple routes, including a 146 
complete life cycle outside of the human host, in the soil. The life cycle routes of greatest public 147 
health relevance however, are those which involve the human host. Filariform larvae can infect 148 
humans both percutaneously and orally (Figure 2D).28 Following penetration of the skin, typically of 149 
the foot, larvae are transported to the right side of the heart and thereafter to the pulmonary 150 
circulation. In the pulmonary capillaries, the larvae penetrate the alveoli, pass to the larynx and are 151 
swallowed to enter the small intestine where they mature to adult worms. Oral infection follows the 152 
same cycle after the larvae penetrate the intestinal mucosa.  153 
The female adult penetrates the gut wall, lodges in the lamina propria of the duodenum and 154 
jejunum and may lay up to 50 eggs a day. The eggs hatch within the gut wall and rhabditiform larvae 155 
migrate in to the lumen and are passed with the stools. The larvae may penetrate the colonic wall or 156 
perianal skin to enter a new cycle, or may disseminate to other organ systems. This aspect of the life 157 
cycle, termed auto-infection, enables chronic infection that may last for several years to decades, 158 
without repeated external exposure.29 Larvae (or unhatched eggs) that are expelled in the stool may 159 
survive in moist soil for several weeks, and develop into infective larvae.30 Strongyloides fuelleborni 160 
which occasionally infects humans, follows the same life cycle.11  161 
 162 
PATHOPHYSIOLOGY  163 
Ascaris lumbricoides may cause disease in humans through type-1 hypersensitivity reactions to 164 
larval stages (Loeffler syndrome), and by physical obstruction caused by adult worms (Figure 3A). 165 
Pathology is positively related to worm burden, albeit non-linearly.25, 31 Common complications in 166 
endemic areas include mechanical small bowel obstruction, volvulus and intussusception, especially 167 
in children.32 Adult worms can further invade intestinal orifices, causing complications such as acute 168 
appendicitis, acute cholecystitis, pancreatitis and gastric ascariasis.33  169 
Ascaris lumbricoides infection may cause malnutrition, including lactose intolerance and vitamin A 170 
deficiency.34, 35 Recent findings suggest that A. lumbricoides might alter the normal intestinal 171 
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bacterial flora,36 although Ascaris may also have a protective effect against severe enteric 172 
infections.37 Anaemia may result from mucosal bleeding in the upper gastrointestinal tract or 173 
through a generalised inflammatory reaction to infection.38  174 
Similar to other helminth infections, A. lumbricoides induces a predominantly type-2 T helper cell 175 
(Th2)-polarised immune response.39, 40 Increased immunoglobulin (Ig)E titres and eosinophilia are 176 
characteristic features of especially acute Ascaris infection. Studies have found a combination of 177 
host-protective and parasite-evading features, regulated by interleukin (IL)-10 and other cytokines.41, 178 
42 A shift in the age of peak infection prevalence and host immune response may be seen as partial 179 
immunity develops.43 Further, host genetic factors may play a role in determining the intensity of 180 
Ascaris infection and disease presentation, including resistance to reinfection.44 Ascaris-induced 181 
immunomodulation may affect the host’s response to co-infections, including HIV, tuberculosis, 182 
malaria and human papillomavirus (HPV).45-48 Ascaris lumbricoides infection may also be a risk factor 183 
for asthma and atopy, possibly through cross-reaction between parasite, mite and insect epitopes.40, 184 
49  185 
Trichuris trichiura worms’ whip-shaped form has given this helminth its common name, whipworm. 186 
The slender anterior aspect of the worm burrows into the intestinal mucosa (Figure 3B), causing 187 
petechial lesions, blotchy mucosal haemorrhage and active mucosal oozing.50 Although not 188 
consistently apparent on endoscopy,50 Trichuris may cause colonic mucosal inflammation,22, 51, 52 189 
which can potentially be influenced by individual immune regulation and gut microbiota.53, 54 190 
Morbidity is positively associated with intensity of infection,55 and trichuriasis can lead to both 191 
mucosal and systemic changes in immune response and resistance to reinfection.56, 57  192 
Eosinophils are a typical feature of especially acute T. trichiura infection, and play a role in local gut 193 
pathology.58 In animal models, Trichuris worm expulsion has been associated with intestinal 194 
epithelial cell turnover, stimulated by cytokine responses.59 In contrast to A. lumbricoides infection, 195 
T. trichiura infection is not associated with changes in intestinal bacterial flora,36 and might even 196 
protect against severe diarrhoeal pathogens.37 Anaemia is a common feature of trichuriasis, and, 197 
although often not as pronounced as in hookworm infection, can have severe consequences in 198 
vulnerable individuals such as pregnant women.50, 60  199 
Ancylostoma duodenale, N. americanus, i.e. hookworm, derives its name from the hook created by 200 
the angle of the head to the rest of the adult worm body. As in A. lumbricoides infection, hookworm 201 
larvae migrating through pulmonary tissue may cause a type-1 hypersensitivity reaction (Loeffler 202 
syndrome). Once established in the small intestine, the adult worm uses its teeth to burrow into the 203 
intestinal mucosa and feed on blood (Figure 3C). This damages the mucosal lining and oozing leads 204 
to blood loss at the site of burrowing. The associated anaemia is the most characteristic feature of 205 
hookworm infection,61 and is a major cause of anaemia globally, particularly in children and 206 
pregnant women.62, 63  207 
As with other helminths, hookworm infection is associated with a Th2 polarised immune response, 208 
regulated by IL-10 and transforming growth factor (TGF)-ß, both systemically and in the local 209 
intestinal mucosa.64 Elevated IgE titres, IL-5 and eosinophilia are features of especially acute 210 
hookworm infection, and may play a role in intestinal immune response. 65However, unlike other 211 
soil-transmitted helminth infections, repeated exposure to hookworm infection has not been found 212 
to stimulate resistance to reinfection, potentially due to a down-regulation of the immune 213 
response.66, 67  214 
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Strongyloides stercoralis larvae migrating through pulmonary tissue may cause a type-1 215 
hypersensitivity reaction, or Loeffler syndrome.68 The adult worms burrow into the intestinal 216 
mucosal wall and cause local inflammation.29 A Th2-dominated immune response is a pivotal factor 217 
in S. stercoralis infection, especially in preventing severe morbidity.69 Eosinophils are a prominent 218 
feature of S. stercoralis infection, and may provide host protection especially in early-stage 219 
infection.70  220 
Severe infection, whether restricted to intestinal and pulmonary pathology or disseminated to 221 
multiple organ systems, appears to be caused by a defective Th2 response that allows the 222 
reproduction of larvae to exceed the number that are effectively controlled by the host’s immune 223 
response.71 Bacterial septicaemia is an independent predictor of shock and mortality in disseminated 224 
infection.72  225 
 226 
CLINICAL PRESENTATION  227 
The distribution of soil-transmitted helminth infections is ‘over-dispersed’, i.e. relatively few heavily-228 
infected individuals harbour the majority of the worms,20, 73, 74 and this may be due to both exposure 229 
and host susceptibility.75 Although most individuals with low and moderate intensity infections 230 
commonly have limited or non-specific symptoms, clinicians should be aware that such infections 231 
also can present as acute and chronic cases.  232 
Ascaris lumbricoides infection is commonly asymptomatic or may produce mild, non-specific 233 
symptoms. In patients who seek health care, symptoms will depend on the phase of the parasite’s 234 
life cycle and the intensity of infection (Table 1). So-called eosinophilic pneumonia, or Loeffler 235 
syndrome, may occur ten to fourteen days after infection and is due to a typically self-limiting 236 
inflammatory reaction to A. lumbricoides larvae migrating through the pulmonary tissue.68, 76 237 
Patients present with urticaria, cough, dyspnoea, and haemoptysis, and may have abnormal 238 
auscultatory breath sounds. In rare cases, the syndrome may result in pleuritis or pleural effusion.77  239 
Infections with adult Ascaris lumbricoides may present as acute abdomen, most frequently in 240 
children with high worm burdens, including upper gastrointestinal bleeding, small bowel 241 
obstruction, intestinal volvulus and intussusception, peritonitis, and gastric ascariasis, even with 242 
perforation.33, 38, 76, 78-80 Hepatobiliary and pancreatic ascariasis may cause five broad clinical 243 
syndromes, including biliary colic, acute cholecystitis, acute pancreatitis, acute cholangitis and 244 
hepatic abscess.81 Hospital-based studies in India have found that Ascaris may be the cause of 245 
approximately half of cases with biliary disease, a third of pancreatitis cases, and around 15% of liver 246 
abscesses and biliary lithiasis.82-84 Clinicians in endemic areas must have a high suspicion of Ascaris 247 
infection, as cases may present as surgical emergencies.  248 
Asthenia, lack of appetite (anorexia), abdominal pain or discomfort, diarrhoea or other altered 249 
bowel habits, and weight loss are common symptoms in intestinal ascariasis. Anaemia and/or occult 250 
or fresh blood in the stool may be found in cases of mucosal haemorrhage, and patients with 251 
intestinal obstruction commonly have findings of abdominal distension, increased bowel sounds and 252 
abdominal tenderness by palpation. Jaundice, fever, and/or abdominal tenderness may be found in 253 
hepatobiliary and pancreatic ascariasis, depending on the clinical syndrome, as described above.76  254 
Trichuris trichiura infection is commonly asymptomatic. Loeffler syndrome does not occur as T. 255 
trichiura does not pass through the lungs. Individuals presenting with symptoms typically complain 256 
of asthenia, abdominal pain, and diarrhoea, and can in severe cases present with Trichuris dysentery 257 
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syndrome (Table 1). Signs include anaemia, digital clubbing, abdominal tenderness, and, in some 258 
cases, rectal prolapse.55 These features may be pronounced in high-intensity infection, which can 259 
lead to severe anaemia.50  260 
Ancylostoma duodenale, N. americanus infections are commonly asymptomatic, and symptoms 261 
depend on stage and intensity of infection (Table 1). Following skin penetration, typically of the feet 262 
or lower leg, so-called “ground itch” may occur – an intense itch at the site of infection with 263 
tortuous, vesicular lesions that follow the trace of the migrating larvae. Although less common than 264 
in ascariasis, eosinophilic pneumonia (Loeffler syndrome) with cough, dyspnoea, and haemoptysis 265 
may occur during larval passage through the lungs.68 In peroral infection, nausea, vomiting, 266 
pharyngeal irritation, cough, and dyspnoea may occur (Wakana syndrome).63  267 
Once the worms are established in the small intestine, symptoms are typically caused by blood loss 268 
and intestinal inflammation, and include asthenia, abdominal pain, and diarrhoea with findings of 269 
pallor, tachycardia, tachypnoea, oedema, abdominal tenderness on palpation, occult blood in the 270 
stool, and occasionally melena.85 In heavy intensity infections, anaemia may be severe, although 271 
most commonly smaller amounts of blood loss gradually deplete the patient of erythrocytes and 272 
nutrients.86 In resource-limited settings, this may aggravate the condition of individuals who are 273 
commonly also prone to undernutrition and malaria, such as children and pregnant women.62 In 274 
contrast to Ascaris, the small size of hookworm makes surgical complications uncommon.  275 
Strongyloides stercoralis infection is commonly asymptomatic in otherwise healthy individuals. 276 
Migration of larvae through the pulmonary tissue may present as eosinophilic pneumonia (Loeffler 277 
syndrome) with cough, dyspnoea, wheezing, and haemoptysis.68 In hyperinfection (see below), 278 
pulmonary infection can become severe and even fatal. Chronic strongyloidiasis may present with 279 
asthenia, anorexia, nausea, abdominal pain, and diarrhoea, and abdominal tenderness on 280 
examination (Table 1).87 So-called larva currens is a common feature of chronic infection, and 281 
presents as an urticarial, serpiginous, migratory lesion that typically is found over the abdomen, 282 
torso, buttocks, and/or groin.29 Lesions typically last for a couple of days and may reoccur weeks to 283 
months later. Rarely, immune-mediated disease may occur, such as reactive arthritis.88  284 
Autoinfection will, in immunocompetent hosts, produce a negligible or minimally symptomatic 285 
chronic disease. However, in immunosuppressed individuals, auto-infection can lead to severe 286 
disease, called Strongyloides hyperinfection syndrome (SHS) that can occur decades after the initial 287 
infection.72 SHS typically presents as intestinal or pulmonary failure. Cutaneous and intestinal 288 
mucosal bleeding may be pronounced, and, if left untreated, SHS has a mortality ratio of close to 289 
100%. Disseminated strongyloidiasis occurs when large numbers of parasites spread beyond the 290 
conventional parasite pathway, and may potentially affect any organ system, including the hepatic, 291 
urogenital, central nervous, musculoskeletal, and cardiovascular organ systems. High-risk individuals 292 
include immunosuppressed patients, i.e. patients on immunosuppressive drugs, especially 293 
corticosteroids and vincristine, and patients with hypogammaglobinaemia, haematologic 294 
malignancies, and HTLV-1 infection.  295 
 296 
DIAGNOSIS 297 
Individual diagnosis of STH requires knowledge of the geographical distribution of the infections, as 298 
well as the varied, and often overlapping, clinical picture of disease. Returning visitors from endemic 299 
areas typically present with acute, light-intensity infections, whereas individuals living in, and 300 
emigrants from endemic areas are prone to repeated exposure and chronic disease, some with very 301 
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high worm burdens.89-91 Besides microscopy, which is widely used for stool diagnosis, antibody 302 
assays, although yet to be standardised, may in well-resourced settings aid diagnosis of returning 303 
travellers with first-time exposure and/or in stool-negative cases.92 Also, novel polymerase chain 304 
reaction (PCR) assays are being developed for STH, both in clinical case management and for public 305 
health purposes; however, the tests have yet to be made broadly available (see Outstanding 306 
research).93, 94 Co-infections with multiple parasites are a common finding in endemic areas, and may 307 
make individual diagnosis challenging.95-97 Table 2 indicates the most common differential diagnoses 308 
that should be considered.  309 
Ascaris lumbricoides. The diagnosis of ascariasis depends on the clinical presentation, and requires 310 
identification of parasite eggs, larvae and/or adult worms. In patients presenting with a clinical 311 
picture of Loeffler syndrome, chest x-ray may show infiltrates (Figure 4), and bronchoscopy may 312 
show evidence of bronchitis. Examination of sputum, bronchoalveolar lavage and/or gastric aspirate 313 
may reveal filariform Ascaris larvae.68 Eosinophilia and increased titres of IgE are associated with 314 
acute, larval infections; however, the response is not specific for Ascaris and may also occur in other 315 
conditions, including other parasite infections and allergies.98  316 
In intestinal infection, light microscopy of stool remains the mainstay of detection and quantification 317 
of A. lumbricoides eggs (see Figure 2 for size and schematic appearance).99-101 Hospital-based 318 
laboratories commonly employ concentration techniques with a higher sensitivity for detection of 319 
eggs in stool samples, whereas simplified, field-friendly tests, such as Kato-Katz, are used in public 320 
health control programmes. Although Kato-Katz egg counts positively correlate with individual worm 321 
burden, results are observer-dependent.19, 102, 103 Treatment-induced worm expulsion can be used for 322 
A. lumbricoides, but is cumbersome and resource-consuming, and rarely used as a primary 323 
diagnostic. Other reliable and relatively field-friendly stool preparation techniques include 324 
McMaster, FLOTAC, and mini-FLOTAC, which concentrate the stool and can be more sensitive than 325 
Kato-Katz.101  326 
All techniques are limited by variability of day-to-day egg excretion in stool, as well as focal 327 
distribution of eggs within each stool sample, which may provide false negative results, especially in 328 
low-intensity infection and post-treatment.101-103 In infants, whose stools may be more liquid than 329 
other age groups in general, concentration methods were reported to be more sensitive than non-330 
concentration methods.104 In early-stage infections, typically seen in returning visitors from endemic 331 
areas, parasite eggs may not appear in stool for months after exposure and onset of symptoms. In 332 
such cases, clinical alertness is required and attention to travel history and clinical symptoms and 333 
signs is essential. An IgG4 enzyme-linked immunosorbent assay (ELISA) assay for detection of A. 334 
lumbricoides haemoglobin (AsHb) has recently been shown to reflect recent Ascaris exposure; 335 
however, the test may cross-react with other helminth co-infections105  336 
In patients presenting with acute abdomen, ultrasonography and plain abdominal x-ray are low cost, 337 
commonly available techniques that may identify A. lumbricoides in the gut, as well as signs of 338 
obstruction, i.e. air-fluid levels, dilated bowel loops and thickened bowel wall (Figure 5).76, 106-108 339 
Computed tomography (CT), including contrast enhanced CT (CECT) and magnetic resonance 340 
imaging (MRI) scans can support the diagnosis, but may not be needed in cases with positive 341 
ultrasonography or plain x-ray.109  342 
Ultrasonography remains the diagnostic tool of choice for suspected hepatobiliary and pancreatic 343 
ascariasis (Figure 6A),76, 81, 110 although its sensitivity may be poor, especially in duodenal 344 
ascariasis.107 Upper endoscopy may identify A. lumbricoides in the duodenum, and endoscopic 345 
retrograde cholangiopancreatography (ERCP) can be used to remove worms from the ducts and 346 
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duodenum (Figure 6B).76, 81 Case reports indicate that capsule endoscopy may be an advanced 347 
diagnostic tool, especially when small intestine pathology is suspected;38, 97 however, it is currently 348 
not commonly used.  349 
Trichuris trichiura. In uncomplicated cases, detection and quantification of parasite eggs by 350 
microscopy is sufficient for diagnosis (see Figure 2), with the same limitations as outlined above for 351 
A. lumbricoides.19, 103 Colonoscopy may detect Trichuris in challenging or severe cases (Figure 7), and 352 
biopsies may be needed to confirm diagnosis.50, 111, 112 In patients presenting with Trichuris dysentery 353 
syndrome, examination and evaluation of anaemia is essential, and microcytic, hypochromic 354 
erythrocytes are typical indicators of any associated iron-deficiency anaemia.  355 
Ancylostoma duodenale, N. americanus. Patients presenting with Loeffler syndrome, although rare, 356 
may be diagnosed with chest x-ray (infiltrates), bronchoscopy (bronchitis), or identification of 357 
filariform larvae in sputum or bronchoalveolar lavage.68 In intestinal infection, detection and 358 
quantification of hookworm eggs in stool is the mainstay of diagnosis (see Figure 2), with the same 359 
limitations as described above for A. lumbricoides.113, 114 In addition, the sensitivity of hookworm 360 
diagnosis by Kato-Katz technique rapidly declines following sampling, and microscopy should be 361 
performed within an hour of slide preparation. Worm expulsion is possible, but rarely used. In well-362 
resourced settings, hookworm may be detected by capsule endoscopy, but is not commonly 363 
applied.85, 115, 116 With any hookworm infection, it is essential to determine the extent of blood loss, 364 
which typically features microcytic, hypochromic anaemia.  365 
Strongyloides stercoralis. In patients presenting with Loeffler syndrome, other than chest x-ray and 366 
bronchoscopy findings as described above for Ascaris and hookworm infections, S. stercoralis larvae 367 
may be detected in sputum, bronchoalveolar lavage or by lung biopsy. In intestinal infection, a single 368 
wet mount stool preparation may reveal filariform S. stercoralis larvae,117 although concentration of 369 
fresh stool collected on three alternate days may be required for diagnosis. The Baermann method 370 
and Koga agar plate culture are among the best techniques to diagnose S. stercoralis100; however, 371 
they are not commonly in use.118 In contrast to other soil-transmitted helminth infections, the Kato-372 
Katz technique is not relevant for diagnosis of Strongyloides. A coproantigen test for S. stercoralis 373 
has been found to be more sensitive than microscopy and the agar plate culture method, and has 374 
low cross reactivity with hookworm, Trichuris and Schistosoma mansoni.119 Duodenoscopy with 375 
duodenal biopsies can reveal eggs, larvae and/or adult worms, and plain abdominal x-ray, CECT and 376 
MRI abdomen may help evaluate gut damage.117  377 
Clinical alertness is vital when patients present with S. stercoralis hyperinfection syndrome, as 378 
infection may occur decades after the initial infection and can lead to organ failure. History of 379 
potential exposure, immunosuppression and a combination of clinical findings and laboratory results 380 
are critical for a rapid and accurate diagnosis. One of the hallmarks of hyperinfection is a high S. 381 
stercoralis worm burden in affected organs, and targeted biopsies may identify S. stercoralis adult 382 
worms, larvae and/or eggs (Figure 8).29 Titres of IgE and eosinophils can be either highly elevated or 383 
depleted, depending on host factors and disease progression.72 Serological tests for S. stercoralis 384 
with methods such as ELISA and luciferase immunoprecipitation, have shown promising results,120-122 385 
and PCR of blood and/or cerebrospinal fluid (CSF) samples is available in some well-resourced 386 
settings.123, 124  387 
 388 
CLINICAL MANAGEMENT AND FOLLOW-UP  389 
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In addition to targeted, disease-specific interventions, health education on the prevention of 390 
infection and reinfection has been found effective in reducing disease burden. Individual patients 391 
should therefore be provided with relevant information, in particular on adequate sanitation and 392 
hygiene facilities and practices, and on the use of footwear to protect against hookworm 393 
infection.125 In endemic areas, patients may be at risk of reinfection, and the WHO recommends 394 
regular preventive chemotherapy, especially in children and pregnant women.126  395 
Ascaris lumbricoides. Albendazole 400 mg or mebendazole 500 mg in a single oral dose, or 396 
mebendazole 100 mg twice a day for three days is recommended in uncomplicated, stable patients 397 
older than 12 months (Table 3).127 Alternatively, ivermectin may be given in a single dose of 150-200 398 
µg/kg of body weight. Albendazole might be slightly more efficacious than mebendazole, with a 399 
single dose of albendazole curing 85% of infected individuals (95% confidence interval (CI): 73%-400 
96%), and three doses curing 92% (95% CI: 83%-100%).128, 129  401 
Patients with intestinal obstruction require intravenous fluids and electrolytes, anthelmintics and, if 402 
systemic infection is suspected, antibiotic treatment. In uncomplicated small bowel obstruction, 403 
orally swallowed contrast medium may prompt worm expulsion more rapidly than observation.130 404 
Patients with worms located in the appendix, small intestines, stomach or oesophagus should be 405 
given anthelmintic drug therapy in addition to any required surgical or endoscopic intervention. 406 
Laparotomy and manual expression or enterotomy to remove the worms, and resection of any 407 
gangrenous tissue may be necessary in persistent cases of small bowel obstruction, volvulus or 408 
intussusception despite conservative primary treatment.76 In unstable cases, anthelmintic treatment 409 
should be given once the patient has been stabilised, or under close monitoring, and with supportive 410 
treatment where necessary. Acute abdomen caused by A. lumbricoides during the second and third 411 
trimesters of pregnancy and in puerperium may be treated with benzimidazoles, although 412 
laparoscopy may be required to exclude other causes.131 Monitoring the effectiveness of treatment 413 
is recommended in cases of A. lumbricoides requiring surgery and in cases with a high worm burden, 414 
and up to three alternate days of stools samples should be examined two weeks post-treatment, 415 
unless the clinical condition indicates earlier follow-up.  416 
Empirical data suggest that hepatobiliary ascariasis may be treated with drug therapy alone.33 If 417 
conservative treatment is unsuccessful, and with any severe systemic infection, worm extraction and 418 
biliary drainage may be done using duodenoscopic basket or ERCP, and nasobiliary catheter.76, 81, 132 419 
In both cases, treatment and follow-up should be ensured through relevant imaging, e.g. 420 
ultrasonography.  421 
Trichuris trichiura. A three day regimen of either albendazole 400 mg, mebendazole 500 mg, or 422 
mebendazole 100 mg twice daily is recommended for adults and children with T. trichiura infection 423 
(Table 3).127 Alternative treatment options are ivermectin 200 µg/kg once daily for three days, or 424 
pyrantel pamoate 11 mg/kg base (maximum of 1 g) once daily for three days. Single albendazole and 425 
mebendazole treatments have a limited effect, and even three doses of albendazole may cure only 426 
83% (95% CI: 73%-93%).129 Iron supplementation should be considered in patients with severe or 427 
symptomatic anaemia, and supportive treatment is warranted in patients with dysentery.50, 133 Due 428 
to the partial efficacy of anthelmintic drugs on T. trichiura infection, cases with high worm load 429 
and/or dysentery should be monitored for effectiveness of treatment.  430 
Given the worms’ physical attachment to the colonic mucosal wall, a case study has suggested that 431 
colonoscopy could be useful for diagnosis and potentially treatment of severe cases of trichuriasis.112 432 
However, endoscopy is currently not commonly used for this purpose, and more efficacious and 433 
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accessible treatment options are needed for T. trichiura. Interestingly, drug combinations of 434 
benzimidazoles and ivermectin, and of benzimidazoles and repurposed veterinary drugs such as 435 
oxantel pamoate and milbemycin may effectively treat Trichuris, and trials are currently being 436 
conducted to determine their dosage, indications and effect in human STH.134 An optimum 437 
therapeutic dose range of 15-30 mg/kg oxantel pamoate was recently defined for T. trichiura 438 
infection in 6-14 year olds.135  439 
Ancylostoma duodenale, N. americanus. Treatment with albendazole or mebendazole is 440 
recommended as described above for uncomplicated Ascaris infection (Table 3),127 although single 441 
dose treatment could be insufficient, and three doses of albendazole may be needed to cure 93% 442 
(95% CI: 81%-100%).128, 129 Data on unspecified hookworm infection in south-eastern Asia suggest 443 
that a single dose of either drug may have limited efficacy as measured by cure rate.136 Iron 444 
supplementation, additional nutritional support and monitoring of treatment effect should be 445 
considered in patients with high worm burden and/or severe anaemia.133 Phase III trials of 446 
tribendimidine, a recently developed broad-spectrum anthelmintic agent, may identify an even 447 
more efficacious treatment option against hookworm and other soil-transmitted helminths.137  448 
Strongyloides stercoralis. Ivermectin 200 µg/kg once daily for two days is recommended for infected 449 
asymptomatic and symptomatic individuals (Table 3).127 Alternatively, albendazole 400 mg may be 450 
given twice daily for seven days, or thiabendazole 25 mg/kg/12 h for three days.138 In Strongyloides 451 
hyperinfection, ivermectin treatment should continue until stool and/or sputum samples are 452 
negative for two weeks. If possible, immunosuppressive treatment should be reduced or 453 
discontinued, and analgesics, hydration, nutritional support and antibiotics should be provided as 454 
indicated. Parenteral therapy may be attempted in cases where oral treatment is not possible, such 455 
as in individuals with severe intestinal morbidity; however, indication and dosage needs to be 456 
considered on a case-by-case basis.139-141  457 
Patients treated for S. stercoralis infection should be followed up with triple stool examinations two 458 
to four weeks post-treatment, and retreatment should be provided if necessary. Strongyloides 459 
serology may be useful for defining cure six months post-treatment. Patients with SHS require 460 
stringent follow-up, including repeat endoscopy, biopsies, and information on preventive measures 461 
(see Clinical presentation) to avoid recurrence.117  462 
Drug-associated safety precautions  463 
Potential side effects of benzimidazoles and ivermectin are mostly mild and self-limiting, although 464 
allergic reactions may require specific treatment and follow-up. Benzimidazoles have been shown to 465 
be teratogenic in experimental animal studies and are not recommended in the first trimester of 466 
pregnancy.127 However, in individuals with high-intensity infection, treatment with mebendazole in 467 
the first trimester may be considered on an individual level, taking into consideration the risk of 468 
treatment with a poorly absorbed anthelmintic versus the risk of potential adverse events. The 469 
safety of benzimidazoles has not been established for children younger than 12 months.  470 
Few studies have investigated drug interactions with benzimidazoles; however, some anti-471 
convulsants may decrease the efficacy of albendazole and mebendazole, and an outbreak 472 
investigation suggested an association between Stevens-Johnson syndrome and co-administration of 473 
metronidazole and mebendazole.54, 142, 143 The quality of generic benzimidazoles is uneven; and many 474 
have inadequate efficacy against STH.144 Contraindications for ivermectin include Loa loa infection, 475 
with potentially fatal side effects, and infections in children and pregnant or lactating women.127 In 476 
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cases of extra-intestinal hookworm and Strongyloides infection, anthelmintic drugs can be taken 477 
with food in order to increase their bioavailability.  478 
 479 
PUBLIC HEALTH CONTROL  480 
Current WHO guidelines recommend MDA of benzimidazoles in areas where A. lumbricoides, T. 481 
trichiura and/or hookworm infection prevalence exceeds 20%; the frequency ranging from one to 482 
three times per year depending on STH prevalence.6, 145 The WHO’s goal for morbidity control for 483 
2020, elimination of STH as a public health problem, is defined as reducing the prevalence of 484 
moderate and heavy intensity infections to <1%, based on egg counts.7 The current school-based 485 
deworming platforms have been shown to reduce intensity and, ultimately, prevalence of infection;7, 486 
8, 146 however, mathematical modelling indicates that additional platforms will be needed to control 487 
hookworm, as prevalence and intensity are typically highest in adults.146, 147 The results of a survey of 488 
experts suggest that STH elimination may still be aspirational in most endemic areas and that 489 
community-wide treatment and increased access to improved WASH will be needed to further 490 
control STH.148 Recently, reviews conducted by the Cochrane and Campbell Collaborations have 491 
questioned the effect of population-level deworming on health outcomes, school performance and 492 
cognition in children (see Controversies).149-151  493 
Public health resolutions endorsed by the World Health Assembly (WHA) have mobilised member 494 
states to scale up STH control programmes, and have stimulated interest in the global distribution, 495 
clinical management, and evidence-based measures to control STH. Both mebendazole and 496 
albendazole are currently donated to the WHO free of charge by Johnson & Johnson and 497 
GlaxoSmithKline, respectively, for mass treatment of at-risk school-age children. For pre-school-age 498 
children, drugs are purchased by governments or other groups and are often co-administered with 499 
vitamin A during child health days.152 Only a single dose is normally administered through mass 500 
deworming campaigns, resulting in acceptable reductions in infection intensity but suboptimal cure 501 
rates, especially in areas with high burden of Trichuris and or hookworm infection. At present, S. 502 
stercoralis is rarely intentionally targeted by STH control programmes, neither through geographical 503 
mapping of infection, mass treatment nor monitoring of treatment effect.11  504 
Several challenges remain towards reaching the WHO targets for 2020. Firstly, although 63% of 505 
school-age children and almost half of pre-school-age children in need of treatment are currently 506 
being dewormed for A. lumbricoides, hookworm, and T. trichiura,1 only 30% and 28% of countries 507 
where these children live, respectively, have achieved the 75% treatment coverage target.153 508 
Secondly, strongyloidiasis is not addressed in the WHO’s STH strategic plan, although its 509 
classification as an STH and the sensitivity of S. stercoralis to MDA of ivermectin, provided in LF- and 510 
onchocerciasis-endemic areas of Africa should make a strong case for targeting it.7, 11 Thirdly, some 511 
60 million school-age children and at-risk women of reproductive age live in LF-endemic areas that 512 
currently benefit from albendazole co-administered through the Global Programme to Eliminate 513 
LF.154 Unfortunately, the success of LF elimination and the scaling back of community-based drug 514 
distribution could increase their risk of STH unless other drug delivery platforms are put in place.155 515 
Trials are being conducted to determine the feasibility of breaking STH transmission in post-LF MDA 516 
settings, and the results may inform a new generation of improved public health control 517 
programmes .52 Finally, some population groups are commonly left out of mass treatment 518 
programmes targeting STH, for example non-attending school-age children and women of 519 
reproductive age, and such at-risk populations require particular attention in both public health 520 




CONTROVERSIES  523 
In 2015, a Cochrane review of randomised clinical trials concluded that there is no population-level 524 
effect of deworming on a range of child health outcomes, including growth and haemoglobin 525 
levels.149 The findings have stirred a heated debate on the effectiveness of mass deworming policies 526 
and programmes as they currently stand.150, 156 Having over the past 15 years synthesised 527 
randomised trials of mass deworming, the Cochrane Collaboration argues there is now reasonable 528 
evidence of little or no effect of deworming on health outcomes, school performance or cognitive 529 
development in children.150 A review conducted independently by the Campbell Collaboration, which 530 
also included data from other experimental trial designs, came to similar conclusions.151, 157 Based on 531 
the findings, the authors suggest that additional policy options be considered to improve child 532 
health and nutrition in areas where mass deworming programmes are currently being implemented.  533 
Critics of the Cochrane and Campbell reviews, on the other side, argue that no long-term trials have 534 
been conducted to determine the effect of periodic deworming, and that failure to detect diluted, 535 
population-level health benefits of mass deworming is an issue of measurement or statistical power 536 
and not a lack of benefit of deworming.156 As such, mass deworming in STH-endemic areas is 537 
warranted as the health benefits of treating individuals infected with STH are well established, mass 538 
distribution of anthelmintics is safe, and population-level deworming is more cost-effective than 539 
testing and treating individuals for infection. In fact, a recent, non-peer reviewed meta-analysis 540 
conducted by World Bank and Harvard University health economists reported a significant weight 541 
gain in dewormed children, highlighting the differing methods and approaches of health science and 542 
economic disciplines in the debate.158 Yet others have suggested that expanding deworming 543 
programmes to include the whole community would more effectively reduce STH prevalence and 544 
result in measurable reductions in morbidity in school-age children.159  545 
Some authors have invoked the ‘hygiene hypothesis’ to argue that elimination of STH transmission 546 
could remove the stimulus needed for maturation of the immune system.160, 161 Whereas some 547 
clinical research is exploring the effects of deliberate low-intensity T. suis and N. americanus 548 
infections on autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and 549 
coeliac disease, 161other data have found a positive association between helminth infections and 550 
atopy, contradicting the ‘hygiene hypothesis’.162 Indeed, a recent review argues that the ‘hygiene 551 
hypothesis’ is not valid with regard to helminth infections, and suggests that research should rather 552 
prioritise identifying potential helminth-derived therapeutic molecules.163  553 
Finally, data suggest that deworming may have beneficial effects on co-infections such as HIV,164, 165 554 
and further research is needed to determine the impact of anthelmintic treatment on malaria.166, 167  555 
 556 
OUTSTANDING RESEARCH  557 
One of the principal bottlenecks for adequate individual diagnosis and management, as well as 558 
public health control of STH, has been insufficient investment in research and development of 559 
diagnostic tools and treatment options. This is especially true for Strongyloides, which has been 560 
called the most neglected of NTDs. Improved, accessible, and affordable diagnostic tools are needed 561 
to facilitate detection of all soil-transmitted helminth infections, particularly where intensity and 562 
prevalence are reduced through mass drug treatment.  563 
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Currently, mainly microscopic techniques are used to determine the distribution of Ascaris, Trichuris 564 
and hookworm in endemic areas for public health control.145 The distribution of all soil-transmitted 565 
helminths is ‘over-dispersed’, i.e. relatively few heavily-infected individuals harbour the majority of 566 
the worms.20, 73, 74, 168  and in order to detect the majority of individuals carrying low-intensity 567 
infections, sensitive, field-friendly tools to diagnose and control infection are needed.  568 
At present, no standardised serological antigen tests exist for STH in humans, although such assays 569 
exist in veterinary medicine for T. vulpis and T. suis.169, 170 Research and development is needed to 570 
determine the potential of serological diagnostic tools for STH, including antibody tests for 571 
assessment of disease transmission in low-endemic areas, and antigen tests for detection of active 572 
infections.92 Multiplex PCR tests for multiple co-infections,96, 171, 172 and the use of next-generation 573 
sequencing to improve primers for PCR and loop-mediated isothermal amplification (LAMP), show 574 
promising results, but require validation as well as adaptation for field-friendly use.173 Even if DNA 575 
amplification methods become field-friendly, challenges to DNA extraction remain, and quality 576 
assurance procedures will be essential.  577 
Although commonly observed in veterinary practice, drug resistance to anthelmintics in humans has 578 
not yet been documented. Enhanced and continued surveillance, novel drug development and drug-579 
combination investigations are needed to address the inherent concerns of the development of 580 
resistance as a consequence of mass distribution programmes.174 Randomised control trials are 581 
currently being conducted to determine the indications and efficacy of tribendimidine, and of 582 
combinations of benzimidazoles and ivermectin, oxantel pamoate, and milbemycin, respectively. If 583 
these drug combinations are deemed safe and effective their combined use could be endorsed for 584 
proactive prevention of drug resistance. Effective vaccines against STH could yield high, long-term 585 
impact on the control of STH. The eukaryote nature of parasites makes development of effective 586 
vaccines challenging; however, both a hookworm and a ‘pan-helminthic’ (targeting ascariasis, 587 
trichuriasis and hookworm infection) vaccine are currently being developed for human use.175, 176  588 
As the global community aims to meet the targets set out in the Sustainable Development Goals 589 
(SDGs), further research is needed to identify relevant WASH interventions that may reduce the 590 
burden of STH.177 High quality evidence to inform alternative control strategies, such as community-591 
wide MDA and vaccination programmes in conjunction with WASH interventions, are needed to 592 
ensure and optimise control of STH. Finally, increased awareness and knowledge of STH is needed 593 
among health care professionals, community health workers, and the general public to improve 594 
clinical case detection and management, and public health control.  595 
 596 
CONCLUSIONS  597 
Soil-transmitted helminth infections, here defined as A. lumbricoides, A. duodenale, N. americanus, 598 
T. Trichiura, and S. stercoralis, are highly prevalent, especially in individuals with limited access to 599 
clean water, sanitation, and hygiene. The clinician must consider STH infection in patients with a 600 
history of exposure in endemic areas and who present with a range of medical and surgical 601 
conditions. Safe and largely effective drugs against Ascaris, hookworm, and Trichuris are donated 602 
free of charge for school-age children in STH-endemic countries; however, the global community has 603 
a way to go to achieve the WHO goal for 2020. Increased knowledge of transmission dynamics and 604 
infection-associated morbidity, refined diagnostic tools, and more effective treatment strategies are 605 
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TABLES  633 
Table 1. Symptoms and signs of soil-transmitted helminth infections  634 
 A. lumbricoides T. trichiura  Hookworm S. stercoralis 
At-risk individuals Children, adults Children, adults Adults, children Adults, children; 
immunosuppress
ed patients (SHS) 
Medical history Unremarkable, or history of STH 
Symptoms 
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Ascites and other 
forms of oedema 
Multi-organ 

















Occult or fresh 
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STH = soil-transmitted helminthiasis; TDS = Trichuris dysentery syndrome; SHS = Strongyloides 635 
hyperinfection syndrome  636 
 637 
Table 2. Differential diagnoses of soil-transmitted helminth infections  638 
Clinical features Differential diagnoses Relevant STH 
Asthenia, anorexia Other infectious diseases, 
autoimmune diseases, other 
causes of anaemia, malignancy, 
non-specific 
All STH, including S. stercoralis 




Hookworm, T. trichiura 
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Loeffler syndrome Pneumonia, asthma, other 
causes of dyspnoea 





infections, inflammatory bowel 
disease, malignancies, non-
specific 
All STH, including S. stercoralis 
Acute abdomen Other causes of acute 




A. lumbricoides, S. stercoralis 
Trichuris dysentery 
syndrome 





Other causes of disseminated 
infection, sepsis, multi-organ 
failure 
S. stercoralis 
STH = soil-transmitted helminthiasis; TDS = Trichuris dysentery syndrome; SHS = Strongyloides 639 
hyperinfection syndrome  640 
 641 
Table 3. Anthelmintic treatment of soil-transmitted helminth infections  642 
 A. lumbricoides T. trichiura Hookworm S. stercoralis 
First choice Albendazole 400 mg Ivermectin 200 
µg per kg once 
daily for 2 days 
Single dose Once daily for 
three days 
Single dose 
OR Mebendazole 500 mg  
Single dose Once daily for 
three days 
Single dose 
OR Mebendazole 100 mg twice daily for three days  
Alternative Ivermectin in a 
single dose of 
150-200 µg/kg 
Ivermectin 200 
µg/kg once daily 
for three days 
 Albendazole may 
be given 400 mg 
twice daily for 
seven days 
OR  Pyrantel 
pamoate 11 
mg/kg base 
(maximum of 1 g) 
once daily for 3 
days 
 Thiabendazole 25 
mg/kg/12 h for 
three days 




Adverse reactions to drugs, first trimester of pregnancy, <1 year of age, anti-
convulsant drug therapy (albendazole and mebendazole); children, pregnant* 
and lactating women, Loa loa co-infection (ivermectin, can be fatal);  
All treatment is oral, except for experimental parenteral treatment in Strongyloides hyperinfection 643 
syndrome (SHS). Additional treatment options may be approved for treatment in humans, including 644 
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combination therapy of benzimidazoles and ivermectin, and of benzimidazoles and oxantel pamoate 645 
or milbemycin against in particular T. trichiura, and tribendimidine for treatment of hookworm. 646 
Adapted from 127. * In women with high-intensity infection, treatment with mebendazole in the first 647 
trimester may be considered on an individual level, taking into consideration the risk of treatment 648 
with a poorly absorbed anthelmintic versus the risk of potential adverse events. 649 
 650 
 651 
FIGURES  652 
Figure 1. Prevalence of Ascaris lumbricoides (A), Trichuris trichiura (B), hookworm (Necator 653 
americanus and Ancylostoma duodenale) (C), and Strongyloides stercoralis (D) by global regions. 654 
Data for (A), (B) and (C) from Pullan et al.2 Data for S. stercoralis are especially scarce and may be 655 
associated with strong publication bias, estimates from data by Schär et al.4 Data from single 656 
community-based studies suggest that S. stercoralis may be present also in Australia, Israel and 657 
Japan (marked as non-endemic on the map). 658 
Figure 2. Transmission of Ascaris lumbricoides (A), Trichuris trichiura (B), hookworm infection (C), 659 
and Strongyloides stercoralis (D). 660 
Ascaris lumbricoides (A). Fertilised eggs get swallowed, release larvae that moult into second-stage 661 
(L2) larvae, that in turn penetrate the host intestinal mucosa and migrate to the pulmonary 662 
circulation. Third-stage (L3) larvae migrate across the alveolar wall, are swallowed again and moult 663 
into fourth-stage (L4) larvae in the small intestine. Adult female A. lumbricoides worms can release 664 
thousands of eggs daily that pass into the environment and hatch to produce larvae that can survive 665 
in the soil for several years.  666 
Trichuris trichiura (B). Infective embryonated eggs are ingested and hatch into larvae that moult in 667 
the small intestine. The larvae develop into adult worms, and continue to reside in the caecum and 668 
the ascending colon. Adult female worms lay several thousand eggs per day, which pass in the stool 669 
and survive in the environment for several months.  670 
Ancylostoma duodenale, Necator americanus (C). Hookworm larvae infect humans by penetrating 671 
bare skin, and are transported to the pulmonary capillaries where they penetrate the alveolar wall, 672 
pass to the larynx and are swallowed. The larvae moult and develop into mature worms in the small 673 
intestine, and female adult worms release thousands of eggs daily that pass in the stool and hatch in 674 
warm, moist, sandy soil or in the faeces to produce rhabditiform, first-stage (L1) larvae. Larvae 675 
become infective after rapid moulting to third-stage (L3) larvae that can survive in the environment 676 
for weeks. 677 
Strongyloides stercoralis (D). Infective filariform larvae may infect humans both percutaneously and 678 
orally. Following penetration of the skin, larvae are transported to the pulmonary circulation, 679 
penetrate the alveoli, pass to the larynx and swallowed to enter the small intestine where they 680 
mature to adult worms. Oral infection follows the same cycle after penetrating the intestinal 681 
mucosa. The female adult lodges in the lamina propria of the duodenum and jejunum and may lay 682 
up to 50 eggs a day that hatch within the gut wall to become rhabditiform larvae that migrate in to 683 
the lumen and are passed with the stools. The larvae may penetrate the colonic wall or perianal skin 684 
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to enter a new cycle, or may disseminate to other organ systems. Larvae (or unhatched eggs) that 685 
get expelled in the stool may survive in moist soil for several weeks, and develop into infective 686 
larvae. 687 
Adapted from www.cdc.gov/parasites. 688 
Figure 3. Endoscopic images of intestinal Ascaris lumbricoides and hookworm co-infection (A), 689 
Trichuris trichiura (B), and hookworm infection (C). 690 
Note the size of the partially visible Ascaris worm in relation to the lumen, as well as multiple blood-691 
filled hookworms visualised through narrow band imaging (A), the whip-shape part (not visible) of 692 
Trichuris burrowed into the mucosa (B), and mucosal bleeding associated with the hookworm 693 
infection (C). With permission by Dr Kunimitsu Inoue. 694 
Figure 4. Eosinophilic pneumonia (Loeffler syndrome).  695 
Posteroanterior chest x-ray of 35-year-old male presenting with fever, tachypnoea, and eosinophilia, 696 
showing bilateral, peripheral mottled infiltrates. Ascaris larvae were identified in sputum and gastric 697 
aspirate samples. (Reprinted from Gelpi AP, Mustafa A. Ascaris pneumonia. The American Journal of 698 
Medicine; 44(3): 377-389. http://www.amjmed.com/ Copyright 1968, with permission from 699 
Elsevier.)  700 
Figure 5. Ascaris-induced intestinal obstruction.  701 
A. Plain abdominal x-ray of 3-year-old female with Ascaris-induced intestinal obstruction showing 702 
air-fluid levels, dilated bowel loops and multiple worm structures, and B. Ileum enterotomy with 703 
extraction of causative bolus of Ascaris worms. (Reprinted from Andrade AM, Perez Y, Lopez C et al. 704 
Intestinal Obstruction in a 3-Year-Old Girl by Ascaris lumbricoides Infestation: Case Report and 705 
Review of the Literature. Medicine; 94(16): e655. http://journals.lww.com/md-journal/ Copyright 706 
2015, with permission from Wolters Kluwer.)  707 
Figure 6. Biliary and pancreatic ascariasis.  708 
A. Abdominal ultrasonography showing the dilated common bile duct containing a thick, long, non-709 
shadowing echogenic strip with a central sonolucent tube (arrow), representing the digestive tract of 710 
Ascaris, and B. Endoscopic retrograde cholangiopancreatography in Ascaris-induced pancreatitis 711 
showing the pancreatic duct containing a filling defect in distal part (arrows) and the common bile 712 
duct containing multiple Ascaris worms. (Reprinted from Khuroo MS, Zargar SA, Yattoo GN et al. 713 
Ascaris-induced acute pancreatitis. The British Journal of Surgery; 79(12): 1335-1338. 714 
https://www.bjs.co.uk/ Copyright 1992, with permission from John Wiley and Sons.)  715 
Figure 7. Trichuris dysentery syndrome.  716 
Colonoscopy of 15-year-old female with Trichuris dysentery syndrome showing massive infestation 717 
of Trichuris worms (posterior segments visible), petechial lesions, mucosal haemorrhages and 718 
oedema. (Reprinted from Khuroo MS, Khuroo MS, Khuroo NS. Trichuris dysentery syndrome: a 719 
common cause of chronic iron deficiency anemia in adults in an endemic area (with videos). 720 
Gastrointestinal Endoscopy; 71(1): 200-204. http://www.giejournal.org/ Copyright 2010, with 721 
permission from Elsevier.)  722 
Figure 8. Strongyloides hyperinfection syndrome.  723 
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Human T-cell lymphotrophic virus (HTLV)-1 positive 62-year-old female with acute respiratory 724 
distress syndrome following high-dose corticosteroids during chemotherapy for cervical cancer. 725 
Bronchoscopy (A) showed diffuse intrabronchial haemorrhage, and microscopy of Papanicolaou 726 
stain of bronchoalveolar lavage fluid (B) revealed multiple filariform S. stercoralis larvae (left image 727 
x20, right image x400). (From Kinjo T, Nabeya D, Nakamura H et al. Acute Respiratory Distress 728 
Syndrome due to Strongyloides stercoralis Infection in a Patient with Cervical Cancer. Internal 729 
Medicine; 54(1): 83-87. http://www.naika.or.jp/imonline/ Awaiting response from permission 730 
request)  731 
  732 
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Panel 1: 733 
FAST FACTS  734 
Soil-transmitted helminths infect humans through faecal-oral transmission or skin penetration. 735 
These infections are among the most common diseases in the world, and are caused by the parasites 736 
Ascaris lumbricoides, Trichuris trichiura, hookworm (Ancylostoma duodenale and Necator 737 
americanus) and Strongyloides stercoralis.  738 
The main risk factors for STH include living in or returning from areas with limited access to 739 
adequate sanitation and hygiene.  740 
Clinical presentation. Most individuals are asymptomatic or experience mild symptoms. So-called 741 
eosinophilic pneumonia, or Loeffler syndrome, may occur 10-14 days after infection with A. 742 
lumbricoides, hookworm or S. stercoralis. It presents as a usually self-limiting urticaria, cough, 743 
dyspnoea, and haemoptysis with abnormal auscultatory breath sounds. Common to all soil-744 
transmitted helminth infections are asthenia, lack of appetite (anorexia), abdominal pain, diarrhoea 745 
or other altered bowel habits and weight loss. Species-specific features in severe cases include:  746 
 Ascaris lumbricoides - Acute abdomen due to upper gastrointestinal bleeding, small bowel 747 
obstruction, intestinal volvulus and intussusception, peritonitis, and hepatobiliary and 748 
pancreatic ascariasis manifesting as biliary colic, acute cholecystitis, acute pancreatitis, acute 749 
cholangitis, and hepatic abscess;  750 
 Trichuris trichiura - A syndrome of anaemia, digital clubbing, abdominal tenderness and, in 751 
some cases, rectal prolapse (Trichuris dysentery syndrome);  752 
 Hookworm - Anaemia, sometimes severe, with pallor, tachypnoea, tachycardia and protein 753 
deficiency;  754 
 Strongyloides stercoralis - Strongyloides hyperinfection syndrome manifests as severe intestinal 755 
and pulmonary inflammation in immunosuppressed (especially corticosteroid-induced) 756 
patients. Disseminated Strongyloides can affect any organ system, including the central 757 
nervous, musculoskeletal, cardiovascular, hepatic and urogenital organs.  758 
Diagnosis. Detection and quantification of A. lumbricoides, hookworm and T. trichiura eggs and of S. 759 
stercoralis larvae in stool by microscopy remains the mainstay of diagnosis, despite low sensitivity, 760 
and at least three stool samples on alternate days may be required to identify the cause of infection. 761 
In early-stage infections, parasite eggs or larvae may not appear in stool, and antibody assays and 762 
polymerase chain reaction (PCR) may aid diagnosis.  763 
Ultrasonography, plain abdominal x-ray, computed tomography (CT), including contrast enhanced 764 
CT, and magnetic resonance imaging (MRI) scans may identify infections and/or determine the 765 
extent of gut pathology. Gastroduodenoscopy, colonoscopy and endoscopic retrograde 766 
cholangiopancreatography (ERCP) may serve as both diagnostic and therapeutic tools, and duodenal 767 
biopsies may identify S. stercoralis eggs, larvae and/or adult worms.  768 
Treatment and follow-up. A. lumbricoides, T. trichiura and hookworm infections may be treated 769 
effectively with albendazole or mebendazole, although repeated treatment might be necessary for 770 
cure, particularly for T. trichiura. S. stercoralis infection may be treated with ivermectin, albendazole 771 
or thiabendazole. Alternative drugs and drug combinations are currently being trialled for treatment 772 
of STH. Follow-up of severe infection is required, including treatment of anaemia if relevant. 773 
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Reinfection is frequent in endemic areas, and periodic re-treatment with an anthelmintic drug is 774 
warranted, in addition to relevant sanitary and hygienic health education.  775 
 776 
Panel 2. Features of clinical versus public health control of STH  777 
Feature or factor 
Clinical diagnosis and 
management 
Public health control 
Diagnosis Individual Community-level (e.g. in selected 
schools) 
Diagnostic criteria Parasitological Residence in an area with STH 
prevalence >20% 
Treatment approach Single or multiple-dose Single-dose periodic mass treatment 
Threshold for treatment Travel history, symptoms 
and signs, positive 
laboratory test  
Estimated prevalence of infection in 
target population 
Treatment objective Parasitological cure Deceased worm burden; reduction in 
transmission 
Ancillary treatment Based on clinical signs and 
symptoms 
Typically, only if included in mass 
treatment (e.g. vitamin A 
supplementation) 
Follow-up Parasitological test of cure; 
improvement in associated 
health conditions 
Not usually done 
Health education 
(sanitation and hygiene) 
Recommended Recommended 
 778 
Panel 3. Search strategy and selection criteria  779 
We searched PubMed, the Cochrane library, MEDLINE and EMBASE without restriction of dates or 780 
language using “epidemiology”, “pathophysiology”, “immunology”, “genetics”, “clinical”, 781 
“diagnosis”, “treatment”, “management” and “research” sequentially in combination with each of 782 
the following terms “soil-transmitted helminths”, “soil-transmitted helminth infections”, “soil-783 
transmitted helminthiasis”, “soil-transmitted helminthiases”, “STH”, “Ascaris lumbricoides”, 784 
“Trichuris trichiura”, “hookworm”, “Ancylostoma duodenale”, “Necator americanus” and 785 
“Strongyloides stercoralis”. Titles and abstracts were reviewed, and if found relevant for this 786 
seminar, included for review of full text. Publications presenting strong evidence, or containing 787 
information especially relevant for the seminar were included in the final reference list, prioritising 788 
publications in the past five years especially. Furthermore, reference lists were reviewed and 789 
additional references included if not already identified through the main search strategy. Book 790 
chapters were included by relevance and importance in the field.  791 
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